Sidoti Csr Issues Optimistic Forecast for USNA Earnings

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Research analysts at Sidoti Csr raised their Q1 2025 earnings estimates for USANA Health Sciences in a research note issued to investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now forecasts that the company will post earnings per share of $0.84 for the quarter, up from their prior forecast of $0.73. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences' Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

USNA has been the subject of a number of other research reports. DA Davidson upgraded USANA Health Sciences to a "hold" rating in a research report on Friday, December 20th. StockNews.com raised shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Thursday, December 19th.

USANA Health Sciences Stock Down 0.7 %

Shares of USNA stock traded down $0.25 on Friday, reaching $35.69. The company's stock had a trading volume of 85,667 shares, compared to its average volume of 84,504. The company has a market capitalization of $680.25 million, a P/E ratio of 12.61, a PEG ratio of 1.25 and a beta of 0.89. The stock's 50 day simple moving average is $37.88 and its 200-day simple moving average is $40.01. USANA Health Sciences has a 12-month low of $31.44 and a 12-month high of $54.81.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the previous year, the business earned $0.59 earnings per share.

Institutional Investors Weigh In On USANA Health Sciences

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp increased its stake in USANA Health Sciences by 5.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 97,375 shares of the company's stock worth $4,405,000 after purchasing an additional 5,205 shares during the period. Panagora Asset Management Inc. increased its stake in shares of USANA Health Sciences by 143.1% in the second quarter. Panagora Asset Management Inc. now owns 28,881 shares of the company's stock worth $1,307,000 after buying an additional 16,999 shares during the period. Rhumbline Advisers raised its holdings in USANA Health Sciences by 7.1% during the 2nd quarter. Rhumbline Advisers now owns 36,486 shares of the company's stock valued at $1,651,000 after buying an additional 2,425 shares during the last quarter. Pzena Investment Management LLC boosted its position in USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company's stock valued at $44,183,000 after buying an additional 191,289 shares during the period. Finally, TD Asset Management Inc grew its holdings in USANA Health Sciences by 26.4% in the 2nd quarter. TD Asset Management Inc now owns 11,500 shares of the company's stock worth $520,000 after acquiring an additional 2,400 shares during the last quarter. Institutional investors own 54.25% of the company's stock.

Insider Transactions at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.33% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.